Stockscreener 앱 받기
4.72
0.00%
0.00
전일 마감가:
$4.72
열려 있는:
$4.7
하루 거래량:
235.01K
Relative Volume:
1.04
시가총액:
$219.90M
수익:
-
순이익/손실:
$-293.42M
주가수익비율:
-0.1761
EPS:
-26.8031
순현금흐름:
$-13.51M
1주 성능:
-7.45%
1개월 성능:
+1.07%
6개월 성능:
+6.07%
1년 성능:
+187.80%
1일 변동 폭
$4.252
$4.85
1주일 범위
$4.252
$5.10
52주 변동 폭
$1.62
$12.46
미네르바 뉴로사이언스 Stock (NERV) Company Profile
명칭
Minerva Neurosciences Inc
전화
617-600-7373
주소
1500 DISTRICT AVENUE, BURLINGTON, MA
Compare NERV vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NERV
Minerva Neurosciences Inc
|
4.72 | 219.90M | 0 | -293.42M | -13.51M | -26.80 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
미네르바 뉴로사이언스 Stock (NERV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citizens | Mkt Outperform |
| 2020-06-08 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-14 | 개시 | BTIG Research | Buy |
| 2019-10-02 | 재확인 | Chardan Capital Markets | Buy |
| 2019-09-25 | 개시 | Chardan Capital Markets | Buy |
| 2019-09-18 | 개시 | William Blair | Outperform |
| 2019-05-31 | 개시 | H.C. Wainwright | Buy |
| 2017-09-01 | 개시 | Citigroup | Buy |
| 2017-03-06 | 재개 | Jefferies | Buy |
| 2016-05-12 | 재개 | Jefferies | Buy |
모두보기
미네르바 뉴로사이언스 주식(NERV)의 최신 뉴스
Federated Hermes reports 17.17% stake in Minerva (NASDAQ: NERV) - Stock Titan
Minerva Neurosciences (NERV) Slides 3.15% as Stock Tests Key Support at $4.52Iron Condor Alert - dars.gov.et
NERVMinerva Neurosciences Inc Options - Finviz
NERV News | MINERVA NEUROSCIENCES INC (NASDAQ:NERV) - ChartMill
Minerva Neurosciences, Inc.(NasdaqCM:NERV) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell 2500 Growth Benchmark - marketscreener.com
Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell 2000 Index - marketscreener.com
Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell 2000 Value Benchmark - marketscreener.com
Minerva Neurosciences, Inc.(NasdaqCM:NERV) added to Russell Microcap Value Benchmark Index - marketscreener.com
Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell 2000 Growth Benchmark - marketscreener.com
Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell 3000E Index - marketscreener.com
Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell Microcap Index - marketscreener.com
Minerva Neurosciences, Inc.(NasdaqCM:NERV) added to Russell 3000E Growth Benchmark - marketscreener.com
Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell 2500 Value Benchmark - marketscreener.com
Price to sales forward of Minerva Neurosciences, Inc – NASDAQ:NERV - TradingView
Minerva Neurosciences, Inc.(NasdaqCM:NERV) added to Russell Small Cap Completeness Index - marketscreener.com
Minerva Neurosciences Inc Actuals & Estimates (NASDAQ:NERV) - TradingView
NERV Forecast — Price Target — Prediction for 2027 - TradingView
Minerva Neurosciences Inc Actuals & Estimates (SWB:4MNA) - TradingView
Minerva Neurosciences Inc Actuals & Estimates (FWB:4MNA) - TradingView
ETFs Investing in Minerva Neurosciences Inc Stocks - TradingView
Minerva Neurosciences Inc Actuals & Estimates (BOATS:NERV) - TradingView
Minerva Neurosciences Inc (NERV) Valuation: PE, PB & Fair Value Analysis - TradingKey
4MNA Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Minerva Neurosciences, Inc – NASDAQ:NERV - TradingView
Price to book forward of Minerva Neurosciences, Inc – NASDAQ:NERV - TradingView
Minerva Neurosciences Inc (NERV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Minerva Neurosciences Inc (NERV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Minerva Neurosciences Inc (NERV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Minerva Neurosciences Inc (NERV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Minerva Neurosciences Inc (NERV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Minerva Neurosciences Inc (NERV) Institutional Confidence - TradingKey
Minerva Neurosciences Inc (NERV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Minerva Neurosciences Inc (NERV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Minerva Neurosciences (NERV) Holds Near Support After Modest Decline: Key Levels in FocusMutual Fund Flow - newsline.com
Minerva Neurosciences (NERV) CFO awarded 680,000 stock options at $4.6800 - Stock Titan
Minerva Neurosciences (NERV) CEO granted 1.69M stock options at $4.68 strike - Stock Titan
Minerva Neurosciences (NERV) grants director 50,000 stock options at $4.68 - Stock Titan
Minerva Neurosciences (NERV) director receives stock options for 50,000 shares - Stock Titan
Minerva Neurosciences grants 50,000 options to director | NERV Insider Trading - Stock Titan
Minerva Neurosciences director granted 50,000 options | NERV Insider Trading - Stock Titan
Minerva Neurosciences (NERV) awards 50,000 stock options to director - Stock Titan
Minerva Neurosciences (NERV) loses 37.5% in 4 weeks, here's why a trend reversal may be around the corner - MSN
NERV: Roluperidone targets negative symptoms in schizophrenia, with pivotal data expected in 2027 - TradingView
Minerva Neurosciences Updates Governance Following 2026 Shareholder Meeting - TipRanks
Minerva Neurosciences (NERV) holders approve officer shield, drop forum clause - Stock Titan
NERV Q1 2026 Earnings: Wider-than-Expected Loss Highlights Ongoing Development CostsHealthcare Earnings Report - newsline.com
Minerva Neurosciences Establishes Scientific Advisory Board - GlobeNewswire
Minerva Neurosciences (NERV) Holds Near Support After Slight Decline: Key Levels to WatchSMA Signal - thelegaladvocate.com
Minerva Neurosciences Announces Sales Agreement with Leerink Partners for Common Stock Offering (Form 8-K Filing) - Minichart
Minerva Neurosciences (NERV) Edges Lower Near Support Level Amid Quiet TradingOBV Breakout - newsline.com
미네르바 뉴로사이언스 (NERV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.64%
자본화:
|
볼륨(24시간):